Alitretinoin in punctate palmoplantar keratoderma

Br J Dermatol. 2019 Apr;180(4):931-932. doi: 10.1111/bjd.17336. Epub 2018 Dec 19.

Authors

P Yilmaz¹, M Medvecz², J Kohlhase³, J Küsel³, J Fischer³, C Has¹

Affiliations

¹ Department of Dermatology, University of Freiburg, Freiburg, Germany.
² Department of Dermatology, Venerology and Dermato-oncology, Semmelweis University, Budapest, Hungary.
³ Institute for Human Genetics, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.

PMID: 30339730
DOI: 10.1111/bjd.17336

No abstract available

Publication types

Letter

MeSH terms

Adaptor Proteins, Vesicular Transport / genetics
Administration, Oral
Adult
Aged
Aged, 80 and over
Alitretinoin / administration & dosage*
Alitretinoin / adverse effects
Cohort Studies
DNA Mutational Analysis
Dermatologic Agents / administration & dosage*
Dermatologic Agents / adverse effects
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Keratoderma, Palmoplantar / diagnosis
Keratoderma, Palmoplantar / drug therapy*
Keratoderma, Palmoplantar / genetics
Male
Middle Aged
Mutation
Treatment Outcome

Substances

AAGAB protein, human
Adaptor Proteins, Vesicular Transport
Dermatologic Agents
Alitretinoin

Supplementary concepts

Keratosis palmoplantaris papulosa